18.07

1.01% 0.18

After Hours: 17.80 -0.27 -1.49%

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $18.07, with a volume of 152.08K. It is up +1.01% in the last 24 hours and down -6.95% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$17.89

Open:

$18.03

24h Volume:

152.08K

Relative Volume:

0.88

Market Cap:

$558.82M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-11.02

EPS:

-1.64

Net Cash Flow:

$11.70M

1W Performance:

+4.57%

1M Performance:

-6.95%

6M Performance:

-15.52%

1Y Performance:

-34.55%

1-Day Range:

$18.02

$18.63

1-Week Range:

$16.92

$18.89

52-Week Range:

$16.56

$30.68

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1200)

Industry

Diagnostics & Research (57)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,012

Twitter

@FulgentGenetics

Next Earnings Date

2024-11-08

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	18.07	558.82M	290.71M	-163.43M	11.70M	-1.64
TMO Thermo Fisher Scientific Inc	521.66	199.82B	42.37B	6.14B	7.78B	15.26
DHR Danaher Corp	238.83	173.66B	23.74B	3.89B	4.98B	7.93
A Agilent Technologies Inc	138.14	38.64B	6.51B	1.29B	1.37B	3.82
IQV Iqvia Holdings Inc	201.43	36.52B	15.32B	1.41B	1.96B	5.95
IDXX Idexx Laboratories Inc	421.76	34.55B	3.84B	866.24M	792.60M	9.80

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

Nov 27, 2024

Fulgent Genetics CEO Ming Hsieh sells $40,663 in stock - Investing.com

Nov 27, 2024

StockNews.com Downgrades Fulgent Genetics (NASDAQ:FLGT) to Sell - Defense World

Nov 27, 2024

Nov 23, 2024

Principal Financial Group Inc. Sells 6,020 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Nov 23, 2024

When (FLGT) Moves Investors should Listen - Stock Traders Daily

Nov 23, 2024

Nov 22, 2024

All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy - MSN

Nov 22, 2024

Nov 19, 2024

10 Best Genomics Stocks To Buy Right Now - Insider Monkey

Nov 19, 2024